A clinical mutation in glucokinase causing maturity-onset diabetes in the young type 2 increases enzyme activity

© 2022 Federation of European Biochemical Societies..

Glucokinase (GCK) is the pancreatic β-cell glucose sensor, and its kinetics are key to that purpose. A slow transition step, displayed as non-hyperbolic kinetics, and a low affinity for glucose characterize GCK. Mutations in GCK associated with maturity-onset diabetes of the young type 2 (MODY2) previously described reduce the functionality of the human pancreatic β-cell, leading to diabetic clinical phenotypes. We present a kinetic characterization of the G448D mutation identified in a MODY2 patient, which is one of the first mutations to exhibit increased functionality. This mutant displays increased activity, high affinity for both Mg2+ -ATP and glucose, hyperbolic kinetics and increased phosphorylation potential. Hyperbolic kinetics and assays in the presence of glycerol indicate that G448D lacks the slow transition step crucial for the pancreatic β-cell glucose sensor function.

Medienart:

E-Artikel

Erscheinungsjahr:

2023

Erschienen:

2023

Enthalten in:

Zur Gesamtaufnahme - volume:597

Enthalten in:

FEBS letters - 597(2023), 11 vom: 01. Juni, Seite 1469-1478

Sprache:

Englisch

Beteiligte Personen:

Aránguiz, Oscar [VerfasserIn]
Rivera, Rodrigo [VerfasserIn]
Durruty, Pilar [VerfasserIn]
Seelenfreund, Daniela [VerfasserIn]
Báez, Mauricio [VerfasserIn]

Links:

Volltext

Themen:

EC 2.7.1.2
Glucokinase
Glucose
Hill coefficient
IY9XDZ35W2
Journal Article
Kinetic parameters
MODY2
Mutation

Anmerkungen:

Date Completed 14.06.2023

Date Revised 15.06.2023

published: Print-Electronic

RefSeq: NM_000162.4

Citation Status MEDLINE

doi:

10.1002/1873-3468.14561

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM350324271